Intensity Therapeutics, Inc. Common stock (INTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $10.13M
Last updated: Nov 17, 2026 at 4:10 PM ET
Intensity Therapeutics, Inc. Common stock (INTS) Statistics
Intensity Therapeutics, Inc. Common stock (INTS) has a market cap of $10.13M and an enterprise value of $1.64M. Revenue fell 208.33% over the last 12 months from the 12 months before. It holds $8.49M more cash than debt, 83.81% of its market cap.
Total Valuation
Enterprise value is 83.81% below the market cap, as cash exceeds debt.
| Market Cap | $10.13M |
|---|---|
| Enterprise Value | $1.64M |
| Latest price (Nov 17, 2026) | $2.66 |
Key Dates
| Last Earnings Date | Nov 5, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 75.71% over 52 weeks and trades 23.56% below its 50-day average.
| Beta (1Y) | 1.36 |
|---|---|
| 52-Week Change | -75.71% |
| 1-Month Change | -19.15% |
| 3-Month Change | -36.67% |
| 6-Month Change | -42.05% |
| Total Return (1Y) | -75.71% |
| Total Return (3Y CAGR) | -62.99% |
| Return vs SPY (1Y) | -86.81% |
| Max Drawdown (1Y) | -81.97% |
| Max Drawdown (3Y) | -98.92% |
| Sharpe Ratio (1Y) | -1.72 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $3.48 |
| 200-Day Average | $4.83 |
| 52-Week Range | $2.80 to $15.00 |
| RSI (14 Days) | 32.0 |
| Average Volume (20 Days) | 14.68K |
Financial Position
Current assets cover 3.68x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.68x |
|---|---|
| Quick Ratio | 3.68x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -157.29% and return on assets is -117.00% over the last 12 months.
| Return on Equity (ROE) | -157.29% |
|---|---|
| Return on Assets (ROA) | -117.00% |
Scores
INTS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was -$26.00K over the last 12 months.
| Revenue | -$26.00K |
|---|---|
| Revenue Growth (YoY) | -208.33% |
| Gross Profit | -$7.00K |
| Operating Income | -$12.37M |
| Pretax Income | -$12.04M |
| Net Income | -$12.04M |
| Reported EPS (TTM) | -$4.37 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 74.34% of the $10.29M in total assets.
| Cash and Equivalents | $8.49M |
|---|---|
| Total Debt | $0 |
| Net Cash | $8.49M |
| Net Cash Per Share | $2.61 |
| Working Capital | $6.92M |
| Shareholder Equity | $7.65M |
| Book Value Per Share | $2.35 |
| Total Assets | $10.29M |
| Total Liabilities | $2.63M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$9.07M |
|---|---|
| FCF Per Share | -$2.78 |
| Depreciation and Amortization | $27.00K |
| Share Repurchases | $684.00K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
INTS does not pay a dividend.
| Buyback Yield | -121.12% |
|---|---|
| Shareholder Yield | -121.12% |
Stock Splits
The last split was a 1-for-25 reverse split on Feb 19, 2026.
| Last Split Date | Feb 19, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:25 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About INTS
What is INTS's market cap?
Intensity Therapeutics, Inc. Common stock has a market cap of $10.13M. Its enterprise value, which adds debt and subtracts cash, is $1.64M.
How many shares of INTS are outstanding?
Intensity Therapeutics, Inc. Common stock has 3.26M shares outstanding.
Does INTS pay a dividend?
No. Intensity Therapeutics, Inc. Common stock does not pay a dividend.
How much debt does INTS have?
Intensity Therapeutics, Inc. Common stock has $0 of total debt and $8.49M of cash and equivalents, a net cash position of $8.49M.
INTS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors